Healthcare

Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn....

Healthcare

Makary Reveals What’s Broken Inside the FDA

After 100 days as FDA Commissioner, Dr. Marty Makary lays out his vision for reform, starting with the broken systems he’s uncovered inside the agency. He confronts the FDA’s failure in the opioi...